Lymphoma & Leukaemia Research Review, Issue 23

In this issue:

CPX-351 liposome vs cytarabine + daunorubicin in AML
Outcomes in infradiaphragmatic Hodgkin lymphoma
PFS as end point for OS in first-line DLBCL
Systemic therapy after IFRT in follicular lymphoma
PET-guided therapy of aggressive NHL
Venetoclax for CLL with 17p deletion
Oral arsenic + ATRA vs IV arsenic + ATRA in APL
Quizartinib in R/R AML
Bendamustine + rituximab as first salvage treatment in CLL
BV + bendamustine salvage in R/R Hodgkin lymphoma

Please login below to download this issue (PDF)

Subscribe